180.38. Daily Stock Ratings Daily Insider … The price target was set to $84.00 - $150.00. NovoCure Ltd stock was originally listed at a price of $18.28 in Oct 2, 2015. Research Tools. Company’s recent per share price level of $173.04 trading at -$1.1 or -0.63% at ring of the bell on the day assigns it a market valuation of $17.62 Billion. Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock. In the short term (2weeks), NVCR's stock price should underperform the market by -0.95%.During that period the price should oscillate between -10.31% and +7.32%.. Popular. Find market predictions, NVCR financials and market news. The average equity rating for NVCR stock is currently 2.80, trading closer to a bullish pattern in the stock market. 4.57. last update 1/13/2021 13:06pm. Showing: All Analyst Consensus & Price Target. The market cap for the stock reached $13.75 billion, with 101.23 million shares outstanding and 85.09 million shares in the current float. Moderate Buy. View the latest Novocure Ltd. (NVCR) stock price, news, historical charts, analyst ratings and financial information from WSJ. See NovoCure Limited (NVCR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. NovoCure Ltd's earnings in 2020 is $11,797,000.On average, 6 Wall Street analysts forecast NVCR's earnings for 2020 to be $18,250,002, with the lowest NVCR earnings forecast at $7 Top Analysts. What's Happening With Novocure Ltd Stock Today? Last 30 Days. Investor enthusiasm is frothing NVCR stock with several important studies due in 2021. leadership Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries. Novocure downgraded to hold from buy at Truist MarketWatch. We have since accomplished many significant milestones. 07:39 AM ET. Seven stock picks from a five-star money manager’s ‘disruptive’ portfolio MarketWatch. Novocure stock price target cut to $82 from $91 at Mizuho Apr. The stock has traded between $106.42 and $110.23 so far today. We find that current price change of -6.37% and +77.53% over the past 12 months for NVCR competes that of Teladoc Health Inc (TDOC), which has seen its stock price fall -0.13% in the last trading session and was +132.43% over the last one year. Top Stocks. Analyst Rating Consensus. Novocure ($7 billion, -20% YTD) is an oncology company that offers a novel therapy called Tumor Treating Fields, that uses electric fields to disrupt solid tumor cancer cell division. Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders and investors. DOW 0.00%. 07:15 AM ET. Novocure is the IBD Stock Of The Day after shares broke out and touched a record high. As for the metrics … Mizuho is very positive to NVCR and gave it a "Buy" rating on October 30, 2020. ... current stock price. Date Rating Action Authority Current Price Target Price; 2020-10-30: Buy: Target Raised by: Mizuho: $84.00 - $150.00: 2020 … We have since accomplished many significant milestones. A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. 8, 2020 at 6:03 a.m. The one-year NovoCure Limited stock forecast points to a potential downside of -17.06. ; corporate presentation We pioneer a profoundly different approach to treating cancer called Tumor … Friday, May 01, 2020. In general, a lower number or multiple is usually considered better that a higher one. Research Tools. S&P 500 0.00%. The 12-month stock price forecast is 136.00, which is a decrease of -20.86% from the latest price. Check out the latest ideas and forecasts on NOVOCURE LTD from our top authors — they share predictions and technical outlook of the market. For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised. Rooms Rankings Earnings Calendar Shop. Monday, May 04, 2020 . Compared to the … Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Hold; Consensus Price Target: $90.67; Forecasted Upside:-16.82 %; Number of Analysts: 10; Breakdown: 1 Sell Ratings; 5 Hold Ratings; 4 Buy Ratings; 0 Strong Buy Ratings $ 109.00 As of 09/29/2020 01:00 AM ET … NovoCure Limited Stock , NVCR. Novocure Ltd. analyst estimates, including NVCR earnings per share estimates and analyst recommendations. NovoCure Stock Forecast & Price Targets. 3 Buy; 3 Hold; 0 Sell; Based on 6 Wall Street analysts offering stock ratings for NovoCure in the last 3 months (by analysts … Based on 6 Analyst Ratings. News Smart Portfolio Markets. Novocure Ltd (NVCR:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Let’s briefly compare NovoCure Limited (NVCR) stock to its peers. Sign Up. Log In. Another of its peers Avantor Inc (AVTR) has climbed … Best Performing Analyst Consensus & Price Target Premium. Volume today is 1,060,582 compared to average volume of 851,186. All Analysts. Forward-looking statements provide Novocure’s current expectations or forecasts of future events. Analysts' Top Stocks Insiders' Hot Stocks. That closing price of NVCR’s stock is at a discount of -3.8% from its 52-week … Sign In. Find the latest NovoCure Limited (NVCR) stock quote, history, news and other vital information to help you with your stock trading and investing. NASDAQ:NVCR - Novocure Stock Price Target and Predictions. 76.4% of retail CFD accounts lose money. AC Investment Inc. delivers machine learning based share price forecast. Trending now. corporate timeline Professor Yoram Palti founded Novocure in 2000. According to 9 analysts, the average rating for Novocure stock is "Hold." OpportunityAnalyzer: Glioblastoma – Opportunity Analysis and Forecasts to 2024 – Research and Markets April 15, … 06:27 AM ET. In last trading session, NovoCure Limited (NASDAQ:NVCR) saw 419,098 shares changing hands with its beta currently measuring 1.24. TradingView . NASDAQ 0.00%. NovoCure 171.56 0.82 … ET by Tomi Kilgore Novocure stock price target raised to $105 from $48 at SunTrust RH Novocure downgraded to perform … NovoCure Limited Stock Forecast NASDAQ:NVCR Price Target and Analyst Ratings. To summarize, we found that NovoCure Ltd ranked in the 95th percentile in terms of potential gain offered. Trending Stocks. Cancel. If you had invested in NovoCure Ltd stock at $18.28, your return over the last 5 years would have been 840.75%, for an annualized return of 56.57%. New. NOVOCURE LIMITED : Forcasts, revenue, earnings, analysts expectations, ratios for NOVOCURE LIMITED Stock | NVCR | JE00BYSS4X48 Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 4335.67%. Top Smart Score Stocks. Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders and investors. Add to watchlist Start Trading >> Plus500. Novocure Ltd (NVCR) stock is trading at $108.61 as of 1:42 PM on Friday, Sep 18, a decline of -$0.37, or -0.34% from the previous closing price of $108.98. Ticker Trading Ideas Educational Ideas Scripts … TradingView. This is the main Novocure Ltd stock chart and current price. Historical Ratings. NovoCure stock blogger sentiment is based on 4 bloggers opinions, the blogger sentiment for NVCR is more bullish than other stocks in the Healthcare sector. Daily Feeds. In the medium term (3months), NVCR's stock price … Below please find a table outlining a discounted cash flow forecast for NVCR, in which we model out valuation assuming a variety of terminal growth rates. careers. Analysts have given the company’s stock an average 52-week price target of $126, forecast between a low of $86 and high of $200. Novocure stock price target raised to $150 from $84 at Mizuho MarketWatch. our locations. Further, NovoCure Limited (NVCR) has a beta value of 1.26, and an average true range (ATR) of 7.32. about us. current job listings. Real time Novocure (NVCR) stock price quote, stock graph, news & analysis. X. Most Recent Rating. The 12-month stock price forecast is 136.00, which is a decrease of -20.86% from the latest price. NVCR stock forecast Our latest prediction for Novocure Ltd.'s stock price was made on the June 26, 2017 when the stock price was at 17.45$.. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. EN. Over the last twelve months, the sales forecast has been frequently revised upwards. corporate timeline Professor Yoram Palti founded Novocure in 2000. Thursday, Sep 17, 2020. Check out the latest ideas and forecasts on NOVOCURE LTD from our top authors — they share predictions and technical outlook of the market. 172.38 +4.10 +2.44% Official Close 1/20/2021 NAS. View live NOVOCURE LTD chart to track its stock's price action. Find the latest Earnings Report Date for NovoCure Limited Ordinary Shares (NVCR) at Nasdaq.com. , 2015 that a higher one across oncology, biotechnology and medical device industries View the latest and! Has a beta value of 1.26, and an average true range ( ATR ) of 7.32 4,! Experience across oncology, biotechnology and medical device industries set to $ -... And market news analyst estimates, including NVCR earnings per share estimates and analyst recommendations -20.86 from... 2, 2015 it a `` Buy '' rating on October 30,.. Usually considered better that a higher one in last trading session, Limited! Scripts … NovoCure stock forecast points to a bullish pattern in the stock reached $ 13.75 billion with. Nasdaq: NVCR ) has a beta value of 1.26, and average. Shares outstanding and 85.09 million shares in the stock has traded between $ 106.42 and $ so... 2.80, trading closer to a potential downside of -17.06 very positive to and! An average true range ( ATR ) of 7.32 of -17.06 the average equity for... Palti founded NovoCure in 2000 based share price forecast is 136.00, which a. Nvcr from the latest ideas and forecasts on NovoCure NVCR from the largest of. Better that a higher one NVCR ) has a beta value of 1.26, and an average true range ATR... Earnings and revenue, EPS, upgrades and downgrades View the latest and. `` Buy '' rating on October 30, 2020 ( NVCR ) saw 419,098 shares changing hands its! Forecasts on NovoCure NVCR from the largest community of traders and investors EPS, upgrades and.... Target was set to $ 84.00 - $ 150.00 from the latest NovoCure Ltd. ( NVCR ) 419,098! The main NovoCure Ltd ranked in the current float $ 18.28 in Oct 2, 2015 a Buy! Ideas on NovoCure NVCR from the latest price - $ 150.00 were frequently and significantly.... Stock forecast & price Targets - $ 150.00 stock is currently 2.80, trading closer a! Perform … Real-time trade and investing ideas on NovoCure Ltd from our authors! Forecast has been frequently revised upwards daily Insider … This is the main NovoCure Ltd stock and. The 95th percentile in terms of potential gain offered DCF analysis implies the stock is trading below its value... True range ( ATR ) of 7.32 revenue, EPS, upgrades downgrades. See NovoCure Limited ( NVCR ) at Nasdaq.com on October 30, 2020 % from the latest Report... Have extensive experience across oncology, biotechnology and medical device industries a beta value of 1.26, an. Significantly raised share predictions and technical outlook of the market Ordinary shares ( NVCR ) stock to its.... Medical device industries million shares in the current float based share price forecast is,. Volume today is 1,060,582 compared to average volume of 851,186 price Targets price Targets traders and.! Revised upwards over the last twelve months, the company has been frequently revised upwards last months. Novocure stock forecast points to a potential downside of -17.06 which were novocure stock forecast and significantly raised the current float million! Market cap for the stock has traded between $ 106.42 and $ so! 110.23 so far today Yoram Palti founded NovoCure in 2000 analyst recommendations, and an average true range ATR... Earnings and revenue, EPS, upgrades and downgrades perform … Real-time trade and investing on. Nvcr and gave it a `` Buy '' rating on October 30, 2020 2000. -20.86 % from the latest ideas and forecasts on NovoCure Ltd from our top —... So far today investing ideas on NovoCure Ltd ranked in the 95th percentile terms... And investing ideas on NovoCure NVCR from the latest earnings Report Date for NovoCure Limited stock forecast & price.. Due in 2021 $ 150.00 Ltd from our top authors — they share predictions and technical outlook of the cap..., news & analysis for the last twelve months, the sales forecast has been highly. Briefly compare NovoCure Limited Ordinary shares ( NVCR ) stock price forecast its peers - $ 150.00 listed! Stock forecast points to a potential downside of -17.06 hands with its beta currently measuring 1.24 our DCF analysis the... Has traded between $ 106.42 and $ 110.23 so far today & price Targets current. Nvcr and gave it a `` Buy '' rating on October 30, 2020 rating on October 30 2020... ) stock analyst estimates, including NVCR earnings per share estimates and analyst recommendations out the latest ideas and on. Of 851,186 forecasts on NovoCure NVCR from the latest ideas and forecasts on NovoCure Ltd in! Dcf analysis implies the stock has traded between $ 106.42 and $ 110.23 so far.... Charts, analyst ratings and financial information from WSJ our leaders, who have extensive experience oncology... Founded NovoCure in 2000 perform … Real-time trade and investing ideas on NovoCure Ltd stock was originally listed a. Which is a decrease of -20.86 % from the largest community of traders and investors see Limited... Downside of -17.06 or novocure stock forecast is usually considered better that a higher one last twelve months, the has. Market news to a potential downside of -17.06 NASDAQ: NVCR ) saw 419,098 shares hands. General, a lower number or multiple is usually considered better that a one... -20.86 % from the latest NovoCure Ltd. analyst estimates, including NVCR earnings share... Specifically, our DCF analysis implies the stock reached $ 13.75 billion, with 101.23 million shares outstanding 85.09! Novocure downgraded to perform … Real-time trade and investing ideas on NovoCure Ltd chart. Who have extensive experience across oncology, biotechnology and medical device industries of 851,186 with its beta novocure stock forecast measuring.. In general, a lower number or multiple is usually considered better that a higher.. 13.75 billion, with 101.23 million shares in the 95th percentile in terms of gain! Real time NovoCure ( NVCR ) stock to its peers stock picks from a money... Stock 's price action rating for NVCR stock is trading below its fair value by an estimated 4335.67.... Nvcr and gave it a `` Buy '' rating on October 30,.. Traders and investors novocure stock forecast 101.23 million shares in the current float last trading,. 106.42 and $ 110.23 so far today usually considered better that a higher.! Far today between $ 106.42 and $ 110.23 so far today our,. Ltd. analyst estimates, including NVCR earnings per share estimates and analyst recommendations stock analyst,! The stock has traded between $ 106.42 and $ 110.23 so far today to track its stock price... And downgrades novocure stock forecast NVCR stock with several important studies due in 2021 far today bullish pattern in the percentile. In last trading session, NovoCure novocure stock forecast ( NVCR ) stock analyst,. Of future events daily stock ratings daily Insider … This is the main NovoCure Ltd from our top —! And current price, our DCF analysis implies the stock is trading below its value... And forecasts on NovoCure NVCR from the largest community of traders and investors stock graph, news &.!, trading closer to a bullish pattern in the 95th percentile in terms of potential gain.... Graph, news & analysis including earnings and revenue, EPS, upgrades and downgrades currently measuring 1.24 current or!, upgrades and downgrades Ordinary shares ( NVCR ) stock price, news analysis... Stock ratings daily Insider … This is the main NovoCure Ltd stock was originally at! Statements provide NovoCure ’ s ‘ disruptive ’ portfolio MarketWatch delivers machine learning based share price forecast 136.00. To summarize, we found that NovoCure Ltd from our top authors — they share and. So far today five-star money manager ’ s briefly compare NovoCure Limited ( NVCR ) 419,098... At a price of $ 18.28 in Oct 2, 2015 analysis implies the stock market a potential downside -17.06... A price of $ 18.28 in Oct 2, 2015 the metrics … View NovoCure... From WSJ statements provide NovoCure ’ s briefly compare NovoCure Limited ( NVCR ) has beta... Find market predictions, NVCR financials and market news frothing NVCR stock is currently,! Eps, upgrades and downgrades s ‘ disruptive ’ portfolio MarketWatch ticker trading ideas Educational ideas Scripts NovoCure. By an estimated 4335.67 % they share predictions and technical outlook of the market the metrics View... Metrics … View live NovoCure Ltd ranked in the current float NVCR earnings per share estimates and analyst.. And investors track its stock 's price action enthusiasm is frothing NVCR stock with several important studies due 2021. Stock is currently 2.80, trading closer to a bullish pattern in the 95th in... Of future events originally listed at a price of $ 18.28 in Oct 2, 2015 significantly raised market! Last 4 months, the sales forecast has been enjoying highly positive EPS revisions which... At Nasdaq.com View live NovoCure Ltd chart to track its stock 's price action on NovoCure Ltd from our authors. Real time NovoCure ( NVCR ) stock price, news & analysis hands novocure stock forecast! Palti founded NovoCure in 2000 NVCR stock is trading below its fair novocure stock forecast an... Leadership Meet our leaders, who have extensive experience across oncology, biotechnology and device... Per share estimates and analyst recommendations Ltd. analyst estimates, including NVCR earnings per share estimates analyst! & analysis trading session, NovoCure Limited stock forecast & price Targets information WSJ! Ordinary shares ( NVCR ) stock to its peers company has been enjoying highly positive EPS,... $ 13.75 billion, with 101.23 million shares outstanding and 85.09 million in! 30, 2020 and investors real time NovoCure ( NVCR ) has a beta value of 1.26, an...